Links between ectopic fat and vascular disease in humans

S Lim, JB Meigs - Arteriosclerosis, thrombosis, and vascular …, 2014 - Am Heart Assoc
The average of overweight individual can have differential fat depots in target organs or
specific compartments of the body. This ectopic fat distribution may be more of a predictive …

Fibrosis imaging: current concepts and future directions

M Baues, A Dasgupta, J Ehling, J Prakash… - Advanced drug delivery …, 2017 - Elsevier
Fibrosis plays an important role in many different pathologies. It results from tissue injury,
chronic inflammation, autoimmune reactions and genetic alterations, and it is characterized …

Assessment of Hepatic Steatosis in Patients Undergoing Liver Resection: Comparison of US, CT, T1-weighted Dual-Echo MR Imaging, and Point-resolved 1H MR …

JR van Werven, HA Marsman, AJ Nederveen, NJ Smits… - Radiology, 2010 - pubs.rsna.org
Purpose To compare the diagnostic performance of ultrasonography (US), computed
tomography (CT), T1-weighted dual-echo magnetic resonance (MR) imaging, and point …

[PDF][PDF] Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease

JB Schwimmer, MS Middleton, C Behling… - …, 2015 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in
children. In order to advance the field of NAFLD, noninvasive imaging methods for …

Ectopic fat and cardiometabolic and vascular risk

S Lim, JB Meigs - International journal of cardiology, 2013 - Elsevier
Given that the variation in how regional adipose tissue handles and stores excess dietary
energy has substantial cardiometabolic implications, ectopic fat distribution might be an …

Pediatric non-alcoholic fatty liver disease: an increasing public health issue

S Berardis, E Sokal - European journal of pediatrics, 2014 - Springer
Non-alcoholic fatty liver disease (NAFLD) is a multifactorial condition that encompasses a
wide spectrum of liver abnormalities ranging from simple liver steatosis to steatohepatitis …

Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding …

S Traussnigg, JM Schattenberg, M Demir… - The Lancet …, 2019 - thelancet.com
Background Norursodeoxycholic acid is an orally administered side chain-shortened
homologue of ursodeoxycholic acid that undergoes hepatic enrichment with …

Quantification of hepatic and visceral fat by CT and MR imaging: relevance to the obesity epidemic, metabolic syndrome and NAFLD

PM Graffy, PJ Pickhardt - The British journal of radiology, 2016 - academic.oup.com
Trends in obesity have continued to increase in the developed world over the past few
decades, along with related conditions such as metabolic syndrome, which is strongly …

Hepatorenal index as an accurate, simple, and effective tool in screening for steatosis

RH Marshall, M Eissa, EI Bluth… - American journal of …, 2012 - Am Roentgen Ray Soc
OBJECTIVE. The hepatorenal index has been reported to be a sensitive and noninvasive
test to quantify steatosis, but it is cumbersome and time-consuming and requires specialized …

Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach

A Alisi, AE Feldstein, A Villani, M Raponi… - Nature reviews …, 2012 - nature.com
Nonalcoholic fatty liver disease (NAFLD) is a multifactorial condition, ranging from simple
steatosis to nonalcoholic steatohepatitis (NASH) with or without fibrosis. NAFLD affects both …